The Market

Diasorin operates in the market for in vitro diagnostics. It produces and distributes reagents to test fluid specimens taken from patients (blood, urine, etc.) in a laboratory setting.

The products developed and distributed by the Diasorin Group are designed specifically for clinical diagnostics applications. They are used by diagnostic laboratories that are part of hospital facilities or operate independently (private diagnostic services laboratories). For the most part, they help physicians in diagnosing different diseases (diagnostic benefit), determining the progress of a disease (prognostic benefit) and assessing the effectiveness of a drug treatment (monitoring benefit).

The market for in vitro diagnostics comprises the following product categories, each of which requires different support technologies:
  • infectious Immunology;
  • immunochemistry;
  • clinical chemistry;
  • hematology, Histology, Cytology;
  • microbiology;
  • genetic Testing.

Within the in vitro diagnostics segment, the Diasorin Group specializes in developing, producing and distributing immunodiagnostics products, which comprises the immunochemistry and infectious immunology product categories.

The immunodiagnostics segment currently accounts for about 25% of the total revenues generated in the in vitro diagnostics market (30bln Euros worldwide). It is extremely concentrated and is characterized by the coexistence of two types of players:
  • large, diversified groups that operate in multiple segments of the in vitro and in vivo diagnostics markets, serve a diversified customer base and pursue a strategy based on volume selling and cross selling;
  • operators specialized in the in vitro diagnostics segment who rely on their ability to innovate and on well established competencies in specific product area.

The immunodiagnostics segment is characterized by major entry barriers due to:
  • need for an R&D organization and technical infrastructures capable of developing complex systems that combine knowhow in information technology, medicine and engineering;
  • need for international distribution network with a highly qualified staff;
  • strict regulations governing both the manufacturing and distribution of products.